We have significant experience treating not only straightforward abdominal aortic aneurysms (AAA), but those that require complex or hybrid techniques.
Medical Services related to Stanley Joseph Chetcuti MD
At the University of Michigan, our Advanced Interventional Cardiology Program offers comprehensive and individualized care, utilizing the latest technologies currently available for angioplasty and stenting, performed by our skilled team of interventional cardiologists.
The University of Michigan Frankel Cardiovascular Center offers both open heart surgery and minimally invasive treatments for aortic aneurysm.
University of Michigan Frankel Cardiovascular Center Aortic Disease program began in 1995 and has a long history of treating all types of aortic disease.
Our mortality rate for open acute aortic dissection repairs is 5.4 percent over the past 5 years, much less than the national average of 25 percent.
We offer multiple treatments for aortic valve disease, including both open-heart surgery and TAVR for those who are at risk for open surgery.
We have performed over 600 aortic valve implants (the most in Michigan) and are among the top programs in the country for heart valve experience.
We treat connective tissue disorders including Marfan's syndrome, Ehlers-Danlos syndrome and Loeys-Dietz syndrome, which can affect the aorta.
University of Michigan Aortic Disease Program treats all kinds of arterial disease, including arteriosclerotic aortic disease (hardening of the arteries).
The FDA-approved Edwards SAPIEN Heart Valve is the only transcatheter aortic valve replacement therapy (or TAVR) approved for use in the United States.
The team of physicians of the Multidisciplinary Aortic Program at the University of Michigan are the most experienced in the state and our clinic is one of the largest in the country, providing our patients with the newest therapies and surgical techniques for all types of aortic diseases.
A research site for the Medtronic CoreValve® and SURTAVI trials, for aortic stenosis patients who are at high or intermediate risk for open-heart surgery.
Treatments for peripheral artery disease or PAD (sometimes called peripheral vascular disease) include both surgical and non-surgical options. All PAD patients are treated using risk factor management and exercise. Surgery is reserved for patients with the most serious symptoms.
The difference between peripheral artery disease or PAD (sometimes called peripheral vascular disease) and heart disease is that the blockages are outside your heart, usually in the legs. While PAD itself isn’t life threatening, it can affect quality of life, and not getting proper medical management can lead to heart attack or stroke. The University of Michigan’s Peripheral Arterial Disease Program brings together a multidisciplinary team of physicians to create a treatment plan tailored to your needs.
University of Michigan Thoracic Aortic Program is one of the largest in the country, with low mortality rates for even complex thoracic aortic surgeries.